Alzamend Neuro, Inc. (NASDAQ:ALZN) Financings

Alzamend Neuro, Inc.

Financings

RaiseDate
Series D Convertible Preferred Stock
Tranche closed: US$7.5M raised · US$1,000 a share
Buyers: Ault Lending, LLC (agreed to purchase up to 25,000 Preferred Shares for $25,000,000; purchased 7,500 Preferred Shares for $7,500,000 at the initial closing)
Use of proceeds: General working capital and corporate purposes, including furthering its clinical trials
Aug 4, 2026
Private placement of series C Convertible Preferred Stock and warrants
Closed: private placement
Use of proceeds: To support the five Phase II clinical trials of AL001 Lithium in Brain studies at Massachusetts General Hospital
Jun 16, 2025

Read by 6ix AI from the company's releases